Please provide your email address to receive an email when new articles are posted on . I was honored to give the Stephen A. Obstbaum, MD, Lecture at the 2022 American Society of Cataract and ...

Please provide your email address to receive an email when new articles are posted on . MIGS with cataract surgery is effective, safe and cost-effective. Considering MIGS for each patient with ...

CHICAGO -- Traditional glaucoma surgery more than doubled the likelihood of treatment success for elevated intraocular pressure (IOP) as compared with the more widely used minimally invasive glaucoma ...

Christine Funke, MD, a glaucoma specialist at Barnet Dulaney Perkins Eye Center in Phoenix, Arizona, discussed how minimally invasive glaucoma surgery (MIGS) has been able to offer her patients better ...

MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

The Hydrus Microstent is a tiny, 8mm flexible nitinol device, which is an implant or instrument made from a nickel-titanium alloy.

Glaucoma is a disease of the optic nerve that can lead to vision loss and permanent blindness. Without proper treatment, a person with glaucoma loses peripheral vision first, followed by the loss of ...

Over a 5-year period, the annual rate of progression in vision loss averaged 0.49 dB with surgery alone, compared with 0.26 dB with surgery plus a Schlemm's canal microstent (Hydrus). The results ...